ArticleJournal of applied clinical medical physics2026
Dynamic blood dose estimates in radiotherapy and correlations with adverse clinical outcomes in brain, head-and-neck, and lung cancer patients.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reducing the dose delivered to major intracranial blood vessels in brain radiotherapy using spot-scanning proton arc therapy.Journal of applied clinical medical physics · 2026Article
- Dynamic blood dose estimates in radiotherapy and correlations with adverse clinical outcomes in brain, head-and-neck, and lung cancer patients.Journal of applied clinical medical physics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIn cancer radiotherapy, radiation-induced lymphopenia (RIL) has been reported to be correlated with adverse clinical outcomes such as reduced locoregional control (LRC), distant-metastasis-free survival (DMFS), and overall survival (OS) in various treatment sites. Frameworks to simulate the radiation dose to circulating blood have been developed in response, and simulated blood dose values have been reported to be correlated with severe RIL and/or adverse clinical outcomes. However, validations with different patient datasets or expansions to additional treatment sites, as well as the identification of particularly relevant blood dose metrics and blood compartments to allow for their inclusion during radiotherapy treatment planning, remain lacking. PURPOSE: This study aims to investigate a potential correlation between simulated blood dose values and adverse clinical outcomes in 215 patients with head-and-neck squamous cell carcinoma (HNSCC), 180 patients with glioblastoma (GBM), and 490 patients with non-small-cell lung cancer (NSCLC), and to identify particularly relevant blood dose metrics and blood compartments to allow for their inclusion during radiotherapy treatment planning and thereby enable the optimization of the estimated dose delivered to circulating blood.
methodsFor all 885 patients, TotalSegmentator was used to automatically delineate additional organs-at-risk (OARs), blood vessels, and tissues which were not already manually delineated for radiotherapy treatment planning. Subsequently, the dynamic HEDOS model, which considers temporal aspects such as blood flow dynamics and treatment delivery time, was used to simulate the radiation dose delivered to circulate blood during radiotherapy. Static blood dose models consisting of the mean dose to the union of all HEDOS blood compartments (D
resultsDuring multivariable Cox regression analysis, the blood dose estimates from the dynamic blood dose model exhibited a statistically significant (p < 0.05) correlation with DMFS and OS in the HNSCC and NSCLC datasets as well as with LRC in the HNSCC dataset. D
conclusionsThe dynamic blood dose model exhibited a statistically significant correlation with adverse clinical outcomes in five out of seven cases, compared to just two cases for the static blood dose models. Consideration of temporal aspects such as blood flow dynamics and treatment delivery time was therefore essential to some of the observed correlations. For each treatment site, particularly relevant blood compartments were identified, allowing for their inclusion during radiotherapy treatment planning as part of future studies which aim to reduce the estimated dose to circulating blood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.